Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: SvájcFázis nélkül

ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury

A legfontosabb adatok

Ki végzi
Ecole Polytechnique Fédérale de Lausanne
Hol
Lausanne és Nottwil (Svájc)Mind a 2 helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
12 fő, tervezett
Kezdés
2026. ápr.
Várható befejezés
2032. ápr.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • ARC-IM Therapy
A regiszteradat frissítve
2026. április 21.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with a spinal cord injury caused by trauma, to test ARC-IM Therapy, a spinal cord stimulation device, to help with walking.

Életkor
18 to 65 years
Nem
All sexes
A betegség stádiuma
Spinal cord injury graded A, B, C, or D on the ASIA Impairment Scale (AIS), at level T10 or higher. The injury happened less than 6 weeks before baseline (subacute) or more than 1 year before enrollment (chronic). Arms must work well enough to bear weight. The area 6 cm (2,4 in) above the tip of the conus must be intact on MRI.
Korábbi kezelés
People who have had stem cells injected into the spinal cord cannot join. People in another drug or device study in the 30 days before cannot join.

A részvétel fő kizáró okai

  • Pregnant or breastfeeding
  • Brain damage or a history of epilepsy
  • Spinal cord injury not caused by trauma (for example ischemic, tumoral, autoimmune)
  • Needs a ventilator, an intrathecal baclofen pump, or has an active implanted device
  • Problems in the implant area, such as spinal stenosis, or conditions like unhealed fractures or kidney, liver or heart disease

A regiszter feltételei, szó szerint

Mind a 25 feltétel megnézéseKevesebb

Ki vehet részt

  • Must be at least 18 years old and no older than 65 years old at the time of enrollment
  • Must be graded A, B, C, or D in the ASIA Impairment Scale (AIS)
  • Must have a SCI level at T10 or higher as determined by ISNCSCI, with the region extending 6 cm above the tip of the conus remaining anatomically intact as determined by MRI
  • Must have sustained their injury either less than 6 weeks prior to baseline (Group "Subacute SCI"), or more than 1 year prior to enrollment (Group "Chronic SCI")
  • Must be suffering from a SCI due to trauma
  • Must have a stable medical, physical and psychological condition as considered by the investigators and the delegated specialists
  • Must have residual upper limb function to use the arms for weight bearing support (as determined by functional demonstration)
  • Must be able to understand and interact with the study team in German, French or English
  • Must agree to comply in good faith with all conditions of the study and to attend all scheduled appointments
  • Must provide Informed Consent as documented by signature prior to any study-related procedures
  • Must have an acceptable or highly effective method of contraception for women of childbearing capacity

Ki nem vehet részt

  • Must not have participated in another clinical study using drugs or medical devices within the 30 days preceding and during the present study
  • Must not have previously been injected with stem cells in the spinal cord
  • Must not have a history of epilepsy
  • Must not have any diseases and conditions that would increase the morbidity and mortality of SCI surgery
  • Must not have any existing contraindication to mobility functions (e.g., unhealed bone fractures, central nervous system disorder, peripheral nerve disorder, etc.)
  • Must not suffer from SCI from other etiology than trauma (ischemic, tumoral, autoimmune, etc.)
  • Must not have any other conditions that would make the subject unable to participate in testing in the judgment of the investigators (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.)
  • Must not be pregnant nor breastfeeding
  • Must not have brain damage
  • Must not require ventilator support
  • Must not have any anatomical limitations in the implantation area as judged by the investigators (e.g., spinal stenosis, limiting protrusions, post-traumatic bone damage at area of implantation)
  • Must not require the use of an intrathecal baclofen pump
  • Must not have any active implanted devices
  • Must not be the investigator him/herself, his/her family members, employees or other dependent persons

Nézd meg, megfelelhetsz-e

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 65 év között vagy?

Helyszínek itt: Svájc

  • Centre Hospitalier Universitaire Vaudois (CHUV)Lausanne, SvájcContact: Jocelyne Bloch, Prof. Dr. MDRésztvevőt keres
  • Schweizer Paraplegiker-Zentrum (SPZ)Nottwil, SvájcContact: Björn Zörner, PD Dr. med. Dr. sc. nat.Toborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

The EIGER study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support and promote recovery of ambulatory functions, such as walking, in people with subacute and chronic spinal cord injury.

A vizsgálat 2 csoportja

  • Subacute SCIA vizsgált kezelés

    Participants having sustained the injury less than 6 weeks prior to baseline (subacute). Participants will be provided with the ARC-IM Therapy.

    Kezelés: ARC-IM Therapy

  • Chronic SCIA vizsgált kezelés

    Participants having sustained the injury more than 1 year prior to enrollment (chronic). Participants will be provided with the ARC-IM Therapy.

    Kezelés: ARC-IM Therapy

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Illeszkedési kérdések
Forrás: NCT07234903: ki vehet részt
A regiszteradat frissítve
2026. április 21.